Depomed, Inc. & Ironwood Pharmaceuticals, Inc. Company Profile
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwoodâs GC-C agonist, is in Phase 3 clinical development for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. The efficacy portion of linaclotideâs development program has been completed and will support the NDA submission for both indications, as well as the MAA submission for the IBS-C indication. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.
News Articles
[Janssen] gets rights to use [Depomed]'s {Acuform} IP to deliver {Nucynta} ER
[Johnson & Johnson]’s [Janssen Pharmaceuticals Inc.] has licensed non-exclusive rights to [Depomed Inc.]’s {Acuform} gastric retentive drug delivery technology. Janssen has also gained other right...
AstraZeneca and Ironwood Pharmaceuticals ink pact for $150 million
AstraZeneca and Ironwood Pharmaceuticals announced an agreement to co-develop and co-commercialize Ironwood’s linaclotide in China. Under the terms of the collaboration, AstraZeneca will make an upf...
Ironwood Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at 8:00 a.m. Eastern Time at the Gran...
Ironwood raises $175M for Linzess launch
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) raised $175 million through the sale of 11% notes due 2024. Ironwood said it will use a portion of the proceeds to support the launch of Linzess linaclotide...
AstraZeneca, Ironwood announce linaclotide collaboration for China
AstraZeneca, a global biopharmaceutical company, and Ironwood Pharmaceuticals, a Cambridge, Mass.-based entrepreneurial pharmaceutical company, have signed an agreement to co-develop and co-commercial...
Ironwood Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2012 at 2:10 p.m. Eastern Time at...
Analyst Downgrades Ironwood Pharma on Expenses
A Cowen & Co. analyst downgraded shares of Ironwood Pharmaceuticals Inc. Monday, citing the company's growing expenses and disappointing early sales of its bowel drug Linzess. THE OPINION: Analyst...
Ironwood Pharmaceuticals to Present at the Credit Suisse 2012 Healthcare Conference
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, 2012 at 4:00 p.m. Mountain Time / 6:00...
Drugs and Medications
These highlights do not include all the information needed to use GRALISE safely and effectively. See full prescribing information for GRALISE. GRALISE™ (gabapentin) tablets Initial U.S. Approval: 1...
Avalon organics essential lift [Ironwood Clay Company, Inc.]
Proquin XR (ciprofloxacin hydrochloride) Extended-Release Tablets, 500 mg
PubMed Articles
Linaclotide: first global approval.
Linaclotide is a once-daily, orally administered, first-in-class agonist of guanylate cyclase-C that is minimally absorbed. It is being developed to treat gastrointestinal disorders by Ironwood Pharma...
This study examined the measurement tools and target symptoms/skills used to assess treatment response during Autism Spectrum Disorder (ASD) intervention trials from 2001 through 2010. Data from 195 p...
BACKGROUND: Our objective was to evaluate the performance of the Food and Drug Administration (FDA) Responder Endpoint for clinical trials in IBS-C, using data from two large Phase 3 clinical trials o...
BACKGROUND & AIMS:: Linaclotide, a minimally absorbed, 14 amino-acid, peptide agonist of guanylate cyclase-C, has shown benefit in a proof-of-concept study for the treatment of patients with irritable...
Clinical Trials
Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women
Depomed's Gabapentin Extended Release is an investigational, extended release formulation of Gabapentin that is being studied for the treatment of Hot Flashes/Hot Flushes in postmenopausal...
Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.
Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.
Companies
Depomed, Inc. & Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwoodâs GC-C agonis...
Almirall, S.A. and Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's GC-C agon...
Forest Laboratories, Inc. & Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's GC-C agon...
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's GC-C agonist, is...
Ironwood Pharmaceuticals, Inc. and Almirall
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Ironwood is located in Cambridge, Mass....
More Information about "Depomed, Inc. & Ironwood Pharmaceuticals, Inc." on BioPortfolio
We have published hundreds of Depomed, Inc. & Ironwood Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Depomed, Inc. & Ironwood Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Depomed, Inc. & Ironwood Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Depomed, Inc. & Ironwood Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Depomed, Inc. & Ironwood Pharmaceuticals, Inc. Drugs and Medications on this site too.
